Publisher's Synopsis
Anxiety and insomnia cause mental suffering and can in many individuals induce a long-lasting disability resulting in high costs to the community. This volume focuses on basic and clinical aspects of anxiety and sleep disorders. Representatives from academia and industry discuss research developments and other issues relevant to the treatment of these disorders. The contributions report the latest neurochemical, neuroendocrinological, electrophysiological and molecular studies which provide a rational basis for the definition of disorders and the development of new drug treatments.;Covering key medical and social issues in the development of anxiolytics and hypnotics, the book should interest pharmacologists, psychiatrists and psychologists, neurologists and neuroscientists, as well as medical and marketing representatives in pharmaceutical industries.
